IU technologies to be promoted to biotech, pharma executives at 2016 BIO International Convention
FOR IMMEDIATE RELEASE
INDIANAPOLIS -- Technologies discovered and developed by Indiana University researchers will be promoted to biotechnology and pharmaceutical executives June 6 through 9 at the 2016 BIO International Convention in San Francisco.
Jennifer Finefield and Katherine Moynihan of the Indiana University Research and Technology Corp. will promote the technologies and build relationships within the biotechnology and pharmaceutical sectors at the conference. IURTC protects, markets and licenses intellectual property developed at Indiana University so it can be commercialized by industry.
Finefield, a senior technology manager, said the conference attracts thousands of leaders in the biotechnology and pharmaceutical sectors.
"We will network with more than 30 companies that have asked about Indiana University technology," she said. "We have also proactively targeted companies based on some of the outstanding technologies that we want to market. These networking meetings will increase the visibility of the IURTC technology portfolio."
Some IU technologies that will be promoted during networking meetings include:
- A therapeutic for polycystic kidney disease created by Bonnie Blazer-Yost, School of Science at IUPUI
- A therapy for healing bones created by Melissa Kacena, School of Medicine
- Diagnostic markers for longevity created by Dr. Alexander B. Niculescu, School of Medicine
- Diagnostic and predictive markers for diabetes created by Dr. Raghu Mirmira, School of Medicine
- Immunotherapy for acute leukemia created by Dr. Sophie Paczesny, School of Medicine
Moynihan, an IURTC technology manager, said she and Finefield will also meet with consultants and venture capitalists at the event.
"These experts could strengthen companies developed through IURTC's Spin Up program, which helps IU researchers license and commercialize their work," she said. "Some of these attendees have funds to invest in that kind of company."
About the Indiana University Research and Technology Corp.
IURTC is a not-for-profit corporation tasked with the protecting and commercializing of technology emanating from innovations by IU researchers. Since 1997, IU research has generated more than 2,700 inventions resulting in over 3,900 global patent applications being filed by IURTC. These discoveries have generated $133 million in licensing and royalty income, including $111 million in funding for IU departments, labs and inventors.